Contineum Therapeutics, Inc. (CTNM)
Contineum Therapeutics, Inc. (CTNM) Insider Trading
Directors, officers and holders of more than 10% of CTNM report their trades in its stock on SEC Form 4, within two business days. Each row below is one Form 4 transaction line. The one-letter code says what kind of transaction it was: only P (purchase) and S (sale) are open-market or private trades; awards, option exercises, tax withholding and gifts carry other codes.
Recent Form 4 transactions
The 50 most recent of 103 transactions on file: 0 with code P, 18 with code S and 32 with other codes.
| Date | Insider | Title | Code | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Sep 8, 2026 | Stengone Carmine N. | CEO and President | M Exercise | 2,500 | $1.01 | $2,525 |
| Sep 8, 2026 | Stengone Carmine N. | CEO and President | M Exercise | 2,500 | Not measured | Not measured |
| Sep 8, 2026 | Stengone Carmine N. | CEO and President | S Sale | 2,500 | $16.46 | $41,142 |
| Aug 3, 2026 | Stengone Carmine N. | CEO and President | S Sale | 2,500 | $16.01 | $40,029 |
| Aug 3, 2026 | Stengone Carmine N. | CEO and President | M Exercise | 2,500 | Not measured | Not measured |
| Aug 3, 2026 | Stengone Carmine N. | CEO and President | M Exercise | 2,500 | $1.01 | $2,525 |
| Jul 9, 2026 | Lorrain Daniel S. | Chief Scientific Officer | M Exercise | 25 | Not measured | Not measured |
| Jul 9, 2026 | Lorrain Daniel S. | Chief Scientific Officer | S Sale | 25 | $16.00 | $400 |
| Jul 9, 2026 | Lorrain Daniel S. | Chief Scientific Officer | M Exercise | 25 | $1.01 | $25 |
| Jul 8, 2026 | Lorrain Daniel S. | Chief Scientific Officer | M Exercise | 1,015 | $1.01 | $1,025 |
| Jul 8, 2026 | Stengone Carmine N. | CEO and President | M Exercise | 2,500 | $1.01 | $2,525 |
| Jul 8, 2026 | Lorrain Daniel S. | Chief Scientific Officer | S Sale | 1,015 | $16.00 | $16,240 |
| Jul 8, 2026 | Lorrain Daniel S. | Chief Scientific Officer | M Exercise | 1,015 | Not measured | Not measured |
| Jul 8, 2026 | Stengone Carmine N. | CEO and President | S Sale | 2,500 | $16.00 | $40,000 |
| Jul 8, 2026 | Stengone Carmine N. | CEO and President | M Exercise | 2,500 | Not measured | Not measured |
| Jul 1, 2026 | Lorrain Daniel S. | Chief Scientific Officer | M Exercise | 4,183 | Not measured | Not measured |
| Jul 1, 2026 | Lorrain Daniel S. | Chief Scientific Officer | S Sale | 5,852 | $15.67 | $91,682 |
| Jul 1, 2026 | Lorrain Daniel S. | Chief Scientific Officer | S Sale | 2,501 | $16.24 | $40,608 |
| Jul 1, 2026 | Lorrain Daniel S. | Chief Scientific Officer | M Exercise | 4,183 | $1.01 | $4,225 |
| Jun 30, 2026 | Stengone Carmine N. | CEO and President | M Exercise | 2,500 | $1.26 | $3,150 |
| Jun 30, 2026 | Watkins Tim | CMO & Head of Development | S Sale | 10,833 | $16.02 | $173,590 |
| Jun 30, 2026 | Stengone Carmine N. | CEO and President | M Exercise | 7,500 | Not measured | Not measured |
| Jun 30, 2026 | Watkins Tim | CMO & Head of Development | M Exercise | 10,833 | $4.50 | $48,749 |
| Jun 30, 2026 | Stengone Carmine N. | CEO and President | M Exercise | 2,500 | Not measured | Not measured |
| Jun 30, 2026 | Lorrain Daniel S. | Chief Scientific Officer | M Exercise | 28,826 | Not measured | Not measured |
| Jun 30, 2026 | Lorrain Daniel S. | Chief Scientific Officer | S Sale | 28,826 | $16.04 | $462,288 |
| Jun 30, 2026 | Lorrain Daniel S. | Chief Scientific Officer | M Exercise | 28,826 | $1.01 | $29,114 |
| Jun 30, 2026 | Stengone Carmine N. | CEO and President | M Exercise | 7,500 | $1.01 | $7,575 |
| Jun 30, 2026 | Watkins Tim | CMO & Head of Development | M Exercise | 10,833 | Not measured | Not measured |
| Jun 30, 2026 | Stengone Carmine N. | CEO and President | S Sale | 10,000 | $16.01 | $160,080 |
| Jun 26, 2026 | Ignelzi Troy A. | Director | A Award | 19,000 | Not measured | Not measured |
| Jun 26, 2026 | Brady Todd R. | Director | A Award | 19,000 | Not measured | Not measured |
| Jun 26, 2026 | Schimmelpennink Evert B. | Director | A Award | 19,000 | Not measured | Not measured |
| Jun 26, 2026 | Boyce Sarah | Director | A Award | 19,000 | Not measured | Not measured |
| Jun 26, 2026 | Ware Olivia C | Director | A Award | 19,000 | Not measured | Not measured |
| Jun 26, 2026 | Miralles Gines Diego | Director | A Award | 19,000 | Not measured | Not measured |
| Jun 26, 2026 | Lyons-Williams Lori | Director | A Award | 19,000 | Not measured | Not measured |
| Jun 1, 2026 | Lorrain Daniel S. | Chief Scientific Officer | S Sale | 4,170 | $13.16 | $54,862 |
| May 1, 2026 | Lorrain Daniel S. | Chief Scientific Officer | S Sale | 300 | $13.84 | $4,152 |
| May 1, 2026 | Lorrain Daniel S. | Chief Scientific Officer | S Sale | 3,870 | $13.06 | $50,542 |
| Apr 6, 2026 | Lorrain Daniel S. | Chief Scientific Officer | S Sale | 4,170 | $13.43 | $56,014 |
| Mar 2, 2026 | Watkins Tim | CMO & Head of Development | S Sale | 3,611 | $15.02 | $54,220 |
| Mar 2, 2026 | Watkins Tim | CMO & Head of Development | M Exercise | 3,611 | $4.50 | $16,250 |
| Mar 2, 2026 | Lorrain Daniel S. | Chief Scientific Officer | S Sale | 4,170 | $15.01 | $62,585 |
| Mar 2, 2026 | Watkins Tim | CMO & Head of Development | M Exercise | 3,611 | Not measured | Not measured |
| Feb 25, 2026 | Stengone Carmine N. | CEO and President | S Sale | 2,700 | $16.02 | $43,242 |
| Feb 25, 2026 | Stengone Carmine N. | CEO and President | M Exercise | 2,700 | $1.26 | $3,402 |
| Feb 25, 2026 | Stengone Carmine N. | CEO and President | M Exercise | 2,700 | Not measured | Not measured |
| Feb 25, 2026 | Lorrain Daniel S. | Chief Scientific Officer | M Exercise | 3,824 | Not measured | Not measured |
| Feb 25, 2026 | Lorrain Daniel S. | Chief Scientific Officer | S Sale | 3,824 | $16.01 | $61,228 |
The full Form 4 history is on the CTNM company page (Insider Trades card, View all).
Questions about this data
Which insider transactions are open-market trades?
Code P (open market or private purchase) and code S (open market or private sale). Code F is shares withheld to pay tax on vesting stock, A is an award from the company, M and X are option exercises and G is a gift. None of those is the insider choosing to buy or sell in the market.
How quickly are insider trades reported?
A Form 4 is due before the end of the second business day after the trade. The date shown is the transaction date from the form.
Who has to file Form 4?
Officers, directors and beneficial owners of more than 10% of a class of the company’s registered equity, under Section 16 of the Securities Exchange Act.
Look up any code in the Form 4 transaction code reference, or read Form 4 codes explained.